Turn Therapeutics Appoints Arthur Golden to Board of Directors
Turn Therapeutics Inc. (TTRX)
Company Research
Source: GlobeNewswire
WESTLAKE VILLAGE, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics (“Turn” or the “Company”), a clinical-stage biotechnology company developing next-generation dermatology, wound, and anti-infective therapies, announces the appointment of Arthur Golden, a senior corporate board advisor with extensive experience in M&A transactions, shareholder relations, compliance, and governance, to its Board of Directors. He has decades of experience as a corporate director, most recently as a Director of Emerson Electric where he served for 24 years and chaired the Corporate Governance and Finance Committees and was a member of the Executive Committee. Mr. Golden brings decades of experience advising complex multinational organizations across regulatory, operational, and corporate development functions. He is currently Senior Counsel at Davis Polk & Wardwell LLP, where he spent more than 40 years as a partner, guiding Fortune 500 companies and emerging enterprises through transformat
Show less
Read more
Impact Snapshot
Event Time:
TTRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TTRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TTRX alerts
High impacting Turn Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
TTRX
News
- Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates [Yahoo! Finance]Yahoo! Finance
- Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate UpdatesGlobeNewswire
- Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D. [Yahoo! Finance]Yahoo! Finance
- Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D.GlobeNewswire
- Turn Therapeutics' GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine [Yahoo! Finance]Yahoo! Finance
TTRX
Sec Filings
- 11/25/25 - Form 4
- 11/24/25 - Form 4
- 11/21/25 - Form 4
- TTRX's page on the SEC website